A detailed history of Baader Bank Aktiengesellschaft transactions in Abb Vie Inc. stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 1,308 shares of ABBV stock, worth $251,005. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,308
Holding current value
$251,005
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $202,465 - $236,434
1,308 New
1,308 $224,000
Q3 2022

May 04, 2023

BUY
$134.21 - $153.93 $1.78 Million - $2.05 Million
13,300 New
13,300 $1.78 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $10.3 Million - $13 Million
-74,522 Reduced 84.86%
13,300 $2.04 Million
Q4 2021

May 17, 2022

BUY
$107.43 - $135.93 $9.43 Million - $11.9 Million
87,822 New
87,822 $11.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $339B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.